Follow on Google News News By Tag * Pharma * Intellectual * Property * Biotech * Patents * Operations * Market * Intelligence * Strategic * Partnering * More Tags... Industry News News By Location Country(s) Industry News
Follow on Google News | Patent Issues in the Development of Biosimilar MedicinesJoin industry professionals at SMi's event in Central London on 21st July 2011; for further information and to register please visit the website.
By: SMi Group Ltd This event covers an extensive range of topics and provides a comprehensive survey and in-depth analysis of IP of biosimilars in advanced markets, specific, detailed focus on insulin analogues and pegylation, development of Monoclonal antibodies regulation and an outline of the future opportunities in developing markets and the EU. The masterclass is headed by an expert, Dr Duncan Curley (director of London-based law practice, Innovate Legal), who has in-depth knowledge and experience of IP law practice; where he has worked on many high-profile cases e.g. Lenzing v Courtaulds (fibre technology), Bespak v 3M (metered dose inhalers for asthma) and acts for a number of multinational companies on freedom to operate, patent clearance and litigation issues. Gaining a deeper understanding into the IP of biosimilars is crucial to the dealing with the difficulties of them reaching the market, spotting future opportunities and developing strategies to help companies in the development of biosimilar medicines for the EU market. Benefits of attending SMi’s CPD accredited masterclass, Patent Issues in the Development of Biosimilar Medicines: Upon completion of this Masterclass, through a combination of presentations and interactive discussion, you will: •Analyse the IP of biosimilars in advanced markets •Discuss patent issues that may arise during the development of biosimilar medicines for the EU market •Debate case studies involving IP evolution, cost effectiveness and business models •Gain knowledge about the development of Monoclonal antibodies regulation •Learn from an extremely experienced Masterclass leader with in-depth and specific knowledge of IP legal practice in the pharmaceutical sector •Gain valuable CPD points through attendance For further information and the opportunity to register online please visit; http://www.smi- End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|